-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Buy on CVS Health, Raises Price Target to $118

Benzinga·07/14/2026 13:26:34
Listen to the news
Truist Securities analyst David Macdonald maintains CVS Health (NYSE:CVS) with a Buy and raises the price target from $108 to $118.